NVIDIA just hit a wall in China — halting production of its H20 AI chip after Beijing urged tech giants like Tencent & ByteDance to stop buying. This chip was tailor-made to dodge US export rules… so why pull the plug now?

In this 7‑minute Ticker Shock deep dive, we break down:

The real story behind the H20 halt

The $17.1B China revenue stake at risk

How it could dent NVIDIA’s earnings by $0.55 per share

Market reaction & analyst outlook

Whether you’re an investor, trader, or AI enthusiast, this is your no‑nonsense, data‑driven breakdown.

🔥 Don’t miss: Subscribe for more sharp, visual market analysis.

#NVIDIA #AI #StockMarket

Viking Therapeutics (VKTX) just dropped a bombshell: their Phase 2 trial for the oral weight-loss pill VK2735 showed strong results—but also a massive dropout rate due to side effects like nausea and vomiting. Investors reacted fast, sending the stock down over 40% in a single day.In this episode of Ticker Shock, we break down:The science behind VK2735’s weight-loss resultsWhy the dropout rate is a red flag for future revenueThe math behind Viking’s projected earnings collapseWhat this means for biotech investors and the obesity drug race📉 Is Viking still a “Buy”? Or is this a speculative trap?🔔 Subscribe for more market deep dives and hit the bell so you never miss a shockwave.

The U.S. Treasury just dropped a game‑changing update to clean energy tax credit rules — and First Solar (FSLR) may be the biggest winner. In this Ticker Shock breakdown, we unpack what the new guidance means, how it impacts solar developers, and why FSLR stock jumped over 10% in a single day.

We’ll cover:

• The 5% safe harbor change — and why big projects must now show real progress

• How this news affects First Solar’s revenue, EPS, and U.S. market dominance

• Analyst reactions and what it could mean for your investment strategy

📈 Don’t miss: Price action charts, potential EPS boost scenarios, and our HOLD verdict until Q3/Q4 results confirm the hype.

💡 This video is for educational purposes only — not financial advice. Always do your own research before investing